We Have an Obligation to Provide Organs for Transplantation After We Die
نویسندگان
چکیده
منابع مشابه
Animal organs for human transplantation: how close are we?
Solid organ transplantation has been, by most measures, a phenomenal success. Nonetheless, the field is plagued by extreme shortages of available organs from a very limited number of donors. One potential solution to this organ availability crisis is the use of animals as organ donors for humans (xenotransplantation). Though the concept remains theoretical, significant advances are being made i...
متن کاملI-36: Preimplantation Genetic Diagnosis - Where Have We Been and Where Are We Going
Preimplantation genetic diagnosis (PGD) is now considered routine in IVF laboratories with micromanipulation capability and access to genetic diagnostic services. The past two decades have witnessed a dramatic increase in the use of PGD, the number of cycles performed, and the indications for which PGD has been used. This increase has been mirrored by a slow, but steady, increase in the range o...
متن کامل3D Printing of Organs for Transplantation: Where Are We and Where Are We Heading?
In the field of transplantation, the demand for organs continues to increase and has far outpaced the supply. This evergrowing unmet need for organs calls for innovative solutions in order to save more lives. The development of new technologies in the field of biomedical engineering might be able to provide some solutions. With the advent of 3D bioprinting, the potential development of tissues ...
متن کاملAcute stroke: we have the treatments and we have the evidence – we need to use them
Despite huge global burden, stroke disease has traditionally received little attention in the general medical press. We review a series of four acute stroke research articles published in a themed issue of the Lancet. Claiborne-Johnston and coworkers presented a scoring system to stratify risk of stroke following transient ischaemic attack. Chalela and colleagues demonstrated that magnetic reso...
متن کاملMay we die twice?
To the Editor: The re-analysis of the INSIGHT trial presented by Mancia and associates recently in Hypertension1 is questionable in some aspects and may not have internal validity. Any conclusion based on analysis of subgroups with a small proportion of the participants of the entire trial should be taken as hypothesis generating and may invalidate it if not established a priori.2 This report d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Transplantation
سال: 2006
ISSN: 1600-6135,1600-6143
DOI: 10.1111/j.1600-6143.2006.01419.x